RecruitingNCT07032961

A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening

Screening for Gastric Pathologies in Elderly and High-Risk Populations Using a Mobile Capsule Gastroscopy System: a Prospective, Multicenter, Population Based Cohort Study

Sponsor

Nanfang Hospital, Southern Medical University

Enrollment

10,000 participants

Start Date

Jun 24, 2025

Study Type

OBSERVATIONAL

Conditions

Gastric Cancer Gastric Ulcer Gastritis Gastric Dysplasia Gastric Mass

Summary

The goal of this is to learn about the effectiveness and feasibility of a novel AI- assisted Mobile Capsule Gastroscopy (MCG) system for detecting gastric pathologies in elderly and high-risk populations. The main question it aims to answer is: Can MCG effectively detect gastric pathologies, including common gastric diseases, gastric cancer, and precancerous lesions, in elderly and high-risk individuals at community health centers? Participants will: Epidemiological, diagnostic, and post-MCG follow-up data generated during participants' involvement in the gastric pathologies public screening program will be collected.

Eligibility

Min Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether a swallowable wireless capsule camera (instead of a traditional endoscope) can effectively screen for stomach diseases — as part of a public health program in Guangzhou, China. **You may be eligible if...** - You are 60 years or older and a permanent resident of Guangzhou who hasn't had a stomach screening in the past 3 years (elderly cohort), OR - You are 45 or older and have at least one risk factor for stomach disease (such as family history, smoking, heavy alcohol use, certain dietary habits, or prior stomach conditions) (high-risk cohort) - You provide written informed consent **You may NOT be eligible if...** - You do not live in Guangzhou - You have already had recent stomach screening - You are not part of either the elderly or high-risk groups Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCollect epidemiological, diagnostic, and follow-up data after MCG examination.

MCG System: GICE-1000 Manufacturer: Guangzhou Side Medical Technology Co., Ltd.

Locations(1)

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07032961

Related Trials

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

NCT045579691 location

Lead-212 PSV359 Therapy for Patients With Solid Tumors

NCT067107567 locations

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

NCT0671013281 locations

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

NCT028388361 location

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT0614703715 locations